Marché du traitement des maladies inflammatoires de l’intestin – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00003491
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

APERÇU DU MARCHÉ

La maladie inflammatoire de l'intestin (MII) est un terme qui est utilisé pour décrire les troubles impliquant une inflammation chronique du tube digestif. Les deux types de MII comprennent notamment la colite ulcéreuse et la maladie de Crohn, qui impliquent généralement une diarrhée sévère, des douleurs abdominales, de la fatigue et une perte de poids. Le traitement de la MII consiste à réduire l’inflammation qui déclenche vos signes et symptômes. Le traitement implique un traitement médicamenteux ou une intervention chirurgicale. Le traitement médicamenteux comprend des médicaments anti-inflammatoires qui incluent en outre des corticostéroïdes et des aminosalicylates tels que la mésalamine (Asacol HD, Delzicol, autres), le balsalazide (Colazal) et l'olsalazine (Dipentum), en fonction de la zone affectée du côlon.< /p>

PORTÉE DU MARCHÉ

Le

“Inflammatoire mondial "Analyse du marché du traitement des maladies intestinales jusqu'en 2028" est une étude spécialisée et approfondie de l'industrie des dispositifs médicaux avec un accent particulier sur l'analyse des tendances du marché mondial. Le rapport vise à fournir un aperçu du marché du traitement des maladies inflammatoires de l’intestin avec une segmentation détaillée du marché par type de classe de médicaments, indication de la maladie, canal de distribution et géographie. Le rapport fournit des statistiques clés sur l'état du marché des principaux acteurs du marché du traitement des maladies inflammatoires de l'intestin et présente les principales tendances et opportunités sur le marché.

SEGMENTATION DU MARCHÉ

  • En fonction du type de classe de médicaments, le marché est segmenté en aminosalicyclates, immunomodulateurs, inhibiteurs du TNF et corticostéroïdes.
  • Sur la base de l'indication de la maladie, le marché est segmenté en maladie de Crohn et colite ulcéreuse
  • En fonction du canal de distribution, le marché mondial du traitement des maladies inflammatoires de l'intestin est classé en pharmacie hospitalière, pharmacie en ligne et pharmacie de détail.
< p>

DYNAMIQUE DU MARCHÉ

Pilotes :

  • Présence de produits en pipeline solides pour le traitement des maladies inflammatoires de l'intestin (MII)
  • Prévalence croissante de la maladie de Crohn et de la colite ulcéreuse

Restrictions :

  • Coût de traitement élevé

CADRE RÉGIONAL

Le rapport fournit un aperçu détaillé de l'industrie, y compris des informations qualitatives et quantitatives. Il fournit un aperçu et des prévisions du marché mondial en fonction de divers segments. Il fournit également la taille du marché. et des estimations prévisionnelles de 2019 à 2028 pour cinq grandes régions, à savoir : l’Amérique du Nord, l’Europe, l’Asie-Pacifique (APAC), le Moyen-Orient et l’Afrique (MEA) et l’Amérique du Sud. chaque région est ensuite sous-segmentée par pays et segments respectifs. Le rapport couvre l'analyse et les prévisions de 18 pays dans le monde ainsi que la tendance actuelle et les opportunités qui prévalent dans la région.

Le rapport analyse les facteurs affectant le marché du côté de la demande et de l'offre et évalue plus en détail la dynamique du marché affectant le marché au cours de la période de prévision, c'est-à-dire les moteurs, les contraintes, les opportunités et les tendances futures. Le rapport fournit également une analyse PEST exhaustive pour les cinq régions, à savoir : l'Amérique du Nord, l'Europe, l'APAC, la MEA et l'Amérique du Sud, après avoir évalué les facteurs politiques, économiques, sociaux et technologiques affectant le marché du traitement des maladies inflammatoires de l'intestin dans ces régions.

IMPACT DU COVID-19 SUR LE MARCHÉ DU TRAITEMENT DES MALADIES INFLAMMATOIRES DE L'INTESTIN

Le COVID-19 a commencé à Wuhan (Chine) en décembre 2019 et depuis lors, il s'est propagé à un rythme rapide dans tout le pays. Les États-Unis, l’Inde, le Brésil, la Russie, la France, le Royaume-Uni, la Turquie, l’Italie et l’Espagne comptent parmi les pays les plus touchés en termes de cas confirmés et de décès signalés. La pandémie de COVID-19 a accru la demande de maladies inflammatoires de l’intestin. traitement à travers le monde.

En raison de la situation du COVID 19, de nombreuses entreprises se sont concentrées sur le développement de vaccins, de produits biologiques et de médicaments efficaces pour prévenir/guérir la maladie. Cependant, en raison de le ralentissement du développement et de la fabrication d'autres produits pharmaceutiques ou biologiques, associé à une perturbation de la chaîne d'approvisionnement, a fait connaître des difficultés au marché en 2020. De plus, en raison des nombreuses limitations du confinement, les soins aux enfants atteints de MII ont été limités à des normes minimales, donner la priorité aux urgences et aux perfusions de produits biologiques et mettre en œuvre des services de télémédecine.

ACTEURS DU MARCHÉ

Le rapport couvre les développements clés du marché du traitement des maladies inflammatoires de l'intestin en tant que stratégies de croissance organique et inorganique. Diverses entreprises se concentrent sur des stratégies de croissance organique telles que les lancements de produits, les approbations de produits et autres tels que les brevets et les événements. Les activités de stratégies de croissance inorganique observées sur le marché étaient des acquisitions, des partenariats et des collaborations. Ces activités ont ouvert la voie à l'expansion des activités et de la clientèle des acteurs du marché. Les payeurs du marché du traitement des maladies inflammatoires de l'intestin sont attendus à des opportunités de croissance lucratives à l'avenir avec la demande croissante de traitement des maladies inflammatoires de l'intestin sur le marché mondial.

Le rapport comprend également les profils d'entreprises clés ainsi que leur analyse SWOT et leurs stratégies de marché sur le marché du traitement des maladies inflammatoires de l'intestin. En outre, le rapport se concentre sur les principaux acteurs de l'industrie avec des informations telles que les profils d'entreprise, les composants et les services proposés, les informations financières des 3 dernières années, l'évolution clé au cours des cinq dernières années.

  • Pfizer Inc.
  • Novartis AG
  • JOHNSON et JOHNSON (Janssen Global Services, LLC)
  • AbbVie Inc.
  • Takeda Pharmaceutical Company Limited
  • ALLERGAN
  • CELGENE CORPORATION
  • Bausch Health
  • UCB, Inc.
  • Cosmo Pharmaceuticals NV

L'équipe de recherche et d'analyse dédiée d'Insight Partner est composée de professionnels expérimentés possédant une expertise statistique avancée et propose diverses options de personnalisation dans l'étude existante.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is inflammatory bowel disease?

Inflammatory bowel disease" (IBD) is a chronic inflammatory condition of the gastrointestinal tract, including Crohn's disease and ulcerative colitis. These conditions cause inflammation of the digestive tract lining, leading to symptoms like abdominal pain, diarrhea, fatigue, and weight loss. Treatment aims to reduce inflammation, manage symptoms, and prevent complications through medication, lifestyle changes, and sometimes surgery. Managing IBD typically requires ongoing medical care and monitoring to maintain remission and improve quality of life.

What factors drive the Inflammatory Bowel Disease Treatment Market?

The key factors driving the Inflammatory Bowel Disease Treatment Market growth are the rising prevalence of crohn's disease and ulcerative colitis and increasing product launches over the projection period. Inflammatory Bowel Disease Treatment Market trends include the technological advancement in IBD treatment. Furthermore, the development of innovative treatments through continuing research as well as encouraging government initiatives are also expected to fuel the market growth.

Who are the major players in the Inflammatory Bowel Disease Treatment Market?

The Inflammatory Bowel Disease Treatment Market has major market players, including AbbVie Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc, Biogen, Novartis AG, Lilly, UCB S.A., CELLTRION INC., Merck & Co., Inc., and Johnson & Johnson Services, Inc.

What was the estimated Inflammatory Bowel Disease Treatment Market size in 2023?

The Inflammatory Bowel Disease Treatment Market was valued at US$ 24.05 billion in 2023.

What are the growth estimates for the Inflammatory Bowel Disease Treatment Market till 2031?

The Inflammatory Bowel Disease Treatment Market is expected to be valued at US$ 31.67 billion in 2031.

Which drug class segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on drug class, the market is segmented into biologics, aminosalicyclates, corticosteroids, and others. The biologics segment held the largest Inflammatory Bowel Disease Treatment Market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.

Which disease indication segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on disease indication, the Inflammatory Bowel Disease Treatment Market is segmented into crohn's disease and ulcerative colitis. The crohn's disease segment is anticipated to hold a significant share by 2031.

The List of Companies - Inflammatory Bowel Disease Treatment Market

  1. AbbVie Inc
  2. Takeda Pharmaceutical Company Limited
  3. Pfizer Inc
  4. Biogen
  5. Novartis AG
  6. Lilly
  7. UCB S.A.
  8. CELLTRION INC.
  9. Merck & Co., Inc.
  10. Johnson & Johnson Services, Inc.
  11. Mindray Medical International Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports